Sign in
Taking people in United StatesNo phase

Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change

Key facts

Who runs it
Women and Infants Hospital of Rhode Island
Where
Providence, United StatesSee the site
Trial code
Status
Recruiting
People taking part
14,820 people, planned
Started
3 Jun 2024
Expected to end
30 Mar 2029
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • COMPASS+
Record updated
13 August 2026

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • all pregnant and postpartum people receiving care at participating sites, who reach a gestational age of 20 or more weeks
  • age > 17 years

Who cannot take part

  • all pregnant and postpartum people receiving care at participating sites, who do not reach a gestational age of 20 or more weeks
  • age < 18 years

This trial is currently available in United States.

  • Women and Infants HospitalProvidence, United StatesContact: Emily Miller, MDTaking people

About the trial

What the trial wants to find out

The collaborative care model (CCM) is a health services intervention that integrates mental health care in primary care settings. The goal of this study is to adapt the CCM to the perinatal care context, including community co-designed adaptations to enhance health equity (COMPASS+). The main objectives of the study are to:

Read full original descriptionShow less

1. Evaluate the effect of COMPASS+ on depression symptom outcomes. Specifically we will evaluate population-level depression symptom trajectories and the prevalence of suicidal ideation among. We will also measure rates of depression response and remission for those who have elevated screen scores (i.e., PHQ9 ≥ 10) 2. Adapt, optimize, and evaluate COMPASS+ implementation strategies to the unique context of perinatal care and evaluate implementation outcomes. The RE-AIM framework will be used to evaluate implementation outcomes (acceptability, appropriateness, feasibility, and fidelity). We hypothesize that variability in effectiveness outcomes will be attributable to variability in fidelity to the implementation strategies or in implementation outcomes. 3. Identify the effect of COMPASS+ on perinatal depression and implementation outcomes across racial and ethnic subgroups.

The 2 groups in the trial

  • COMPASS+Treatment being tested

    COMPASS+ services are embedded into the perinatal practice. COMPASS+ includes mental health support services and monitoring by a behavioral health care manager, a patient registry to track participant response to treatment, and weekly team huddles supervised by a perinatal psychiatrist to discussed new participants in the program or individuals who are not symptomatically improving. Patients are eligible for referral to COMPASS+ during pregnancy through one year postpartum.

  • Usual careNo study treatment, for comparison

    Perinatal care practices support the mental health needs of patients providing usual care workflows at their clinic (e.g. screening for depression and anxiety symptoms in each trimester and postpartum, referring patients to community resources)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Collaborative Care Model for Perinatal Depression Support Services -- Population-Level Equity-Centered Systems Change (COMPASS-PLUS): A Hybrid Type 2 Cluster Randomized Trial
Record updated
13 August 2026